GFN•TV: News and Interviews

Australia’s prescription-only model continues to make legal nicotine vapes difficult to access—blocking smokers who want to quit and vapers who need to stay off cigarettes. In this episode, meet Dr. Carolyn Beaumont as she reveals the challenges, controversies, and consequences of being one of the only doctors in the world prescribing nicotine in a country at war with vaping.

Featuring:
DR. CAROLYN BEAUMONT, MD
Australian General Practitioner/Family Physician

Could safer products such as nicotine pouches offer a solution to significantly high rates of tobacco use in Eastern Europe and Central Asia? Joining us today is Giorgi Mzhavanadze, an economist who has worked with Knowledge-Action-Change on the Global State of Tobacco Harm Reduction report, to highlight trends in tobacco use in the region.

Mexico's smoking rates have stagnated, so why is the government insisting on amending their constitution to ban vapes? Tomás O'Gorman joins us to explain these latest developments in Mexico in this brand new episode of GFN News!

Why has New Zealand's smoking rate dropped so far below Australia's in recent years, and what can we subsequently learn from New Zealand's approach to safer nicotine products? In this episode of GFN News THR advocate Colin Mendelsohn highlights the striking difference in approach to vaping in New Zealand and Australia. Enjoy!

In Canada, youth vaping dominates the public health debate—but what about the millions of adult smokers left behind? Dr. Mark Tyndall reveals how fear, misinformation, and political convenience are obstructing access to safer nicotine products. Is Canadian public health failing its most vulnerable by rejecting harm reduction?

Featuring:
DR MARK TYNDALL
Professor UBC SPPH, Infectious Diseases Doctor
Advocate for Human Rights
@DrMtyndall

Low nicotine cigarettes form the basis of the FDA's latest plan to reduce tobacco consumption, but will it actually work? Will Godfrey of Filter Magazine joins us to discuss the details of this proposal, and why this not-so-new idea may cause a significant headache for US smoking cessation efforts.

Germany's lawmakers have recently proposed a new ban on menthol flavours in safer nicotine products, but given that menthol is a key ingredient in over 80% of the flavours currently available on the market, could this proposed ban negatively impact the availability of safer nicotine products for people looking to quit smoking? Joining us today is Michael Landl, Director of the World Vapers' Alliance, to unpack Germany's proposals and the actions consumers are taking to make their voices heard in this debate.

Despite governments around the world endorsing safer nicotine in the form of nicotine replacement therapy, there remain widespread misconceptions about the safety of nicotine compared to harmful combustible tobacco. In the second part of our series exploring the therapeutic uses of nicotine, Michael Kariuki walks us through the current clinical uses of nicotine and the opportunity posed by safer nicotine products to greatly reduce smoking related mortality.

Public health’s war on vaping didn’t start with vaping—it began decades ago with secondhand smoke. The same deceptive tactics now target tobacco harm reduction. How did it begin, and where does it lead? Don’t miss this special two-part episode featuring renowned tobacco control expert Dr. Michael Siegel.

Featuring:
DR. MICHAEL SIEGEL, MD, MPH
Prof., Dept. of Public Health and Community Medicine
Tufts University School of Medicine
Professor Siegel on X
tobaccoanalysis.blogspot.com

In the second part of our series looking at Malawi's complicated relationship with tobacco production and smoking, Sahan Lungu joins us to explore whether a holistic approach to tobacco production and smoking could help Malawi minimise the harms related to combustible tobacco use.